Lixte Biotechnology Holdings Inc (LIXTW) — Financial Flexibility Index
Lixte Biotechnology Holdings Inc (LIXTW) has a Financial Flexibility Index of -1.78x as of September 2025. Free cash flow of $-926.75K (operating CF $-926.75K minus capex $2.00) represents -2% of total liabilities ($521.42K). Check LIXTW intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Lixte Biotechnology Holdings Inc Financial Flexibility Index (2005–2024)
Historical Financial Flexibility Index trend for Lixte Biotechnology Holdings Inc across 20 annual periods. For the full cash flow conversion analysis, see LIXTW operating cash flow.
Annual Financial Flexibility Index for Lixte Biotechnology Holdings Inc (2005–2024)
Year-by-year free cash flow to debt coverage for Lixte Biotechnology Holdings Inc. Explore LIXTW debt coverage from operations to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -9.94x | $-3.16 Million | $-3.16 Million | $318.28K | ▲ +27.3% |
| 2023 | -13.68x | $-4.29 Million | $-4.29 Million | $313.86K | ▼ -17.1% |
| 2022 | -11.68x | $-4.61 Million | $-4.61 Million | $394.79K | ▲ +14.6% |
| 2021 | -13.68x | $-4.14 Million | $-4.14 Million | $302.93K | ▼ -38.9% |
| 2020 | -9.84x | $-2.13 Million | $-2.13 Million | $216.52K | ▼ -39.9% |
| 2019 | -7.04x | $-1.67 Million | $-1.67 Million | $237.90K | ▲ +1.8% |
| 2018 | -7.16x | $-1.51 Million | $-1.51 Million | $210.91K | ▼ -89.2% |
| 2017 | -3.79x | $-1.41 Million | $-1.41 Million | $373.02K | ▲ +50.7% |
| 2016 | -7.67x | $-1.68 Million | $-1.68 Million | $218.65K | ▼ -0.5% |
| 2015 | -7.64x | $-2.18 Million | $-2.18 Million | $285.64K | ▼ -27.7% |
| 2014 | -5.98x | $-1.64 Million | $-1.64 Million | $273.44K | ▼ -63.1% |
| 2013 | -3.67x | $-1.18 Million | $-1.18 Million | $321.77K | ▲ +20.6% |
| 2012 | -4.62x | $-1.21 Million | $-1.21 Million | $261.15K | ▼ -19.1% |
| 2011 | -3.88x | $-1.36 Million | $-1.36 Million | $350.75K | ▲ +19.2% |
| 2010 | -4.80x | $-936.39K | $-936.39K | $195.06K | ▼ -125.8% |
| 2009 | -2.13x | $-638.44K | $-638.44K | $300.26K | ▼ -33.5% |
| 2008 | -1.59x | $-597.69K | $-597.69K | $375.20K | ▲ +42.8% |
| 2007 | -2.79x | $-702.60K | $-702.87K | $252.18K | ▲ +21.7% |
| 2006 | -3.56x | $-442.95K | $-443.45K | $124.50K | ▼ -35.3% |
| 2005 | -2.63x | $-32.87K | $-32.87K | $12.50K | — |